Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Selecting antigens for cancer vaccines

Nature Biotechnology volume 30, pages 328–329 (2012)Cite this article

Subjects

A cancer vaccine is streamlined by identifying a small set of potent immunogens in a tumor cDNA library.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Screening to identify melanoma antigens in immune mice.

Katie Vicari

References

  1. Le, D.T., Pardoll, D.M. & Jaffee, E.M. Cancer J. 16, 304–310 (2010).

    Article  CAS  Google Scholar 

  2. Kottke, T. et al. Nat. Med. 17, 854–859 (2011).

    Article  CAS  Google Scholar 

  3. Vile, R. et al. Nat. Biotechnol. 30, 337–343 (2012).

    Article  Google Scholar 

  4. Naftzger, C. et al. Proc. Natl. Acad. Sci. USA 93, 14809–14814 (1996).

    Article  CAS  Google Scholar 

  5. Muranski, P. et al. Blood 112, 362–373 (2008).

    Article  CAS  Google Scholar 

  6. Avogadri, F. et al. PLoS One 5, e12670 (2010).

    Article  Google Scholar 

  7. Sharma, P., Wagner, K., Wolchok, J.D. & Allison, J.P. Nat. Rev. Cancer 11, 805–812 (2011).

    Article  CAS  Google Scholar 

  8. Quezada, S.A., Peggs, K.S., Curran, M.A. & Allison, J.P. J. Clin. Invest. 116, 1935–1945 (2006).

    Article  CAS  Google Scholar 

  9. van den Eertwegh, A.J.M. et al. Lancet Oncol., published online, doi:10.1016/S1470–2045 (10 February 2012).

  10. Schwartzentruber, D.J. et al. N. Engl. J. Med. 364, 2119–2127 (2011).

    Article  CAS  Google Scholar 

  11. Hodi, F.S. et al. N. Engl. J. Med. 363, 711–723 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Francesca Avogadri and Jedd D. Wolchok are at Swim Across America Laboratory, Ludwig Center for Cancer Immunotherapy and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.,

    Francesca Avogadri & Jedd D Wolchok

Authors
  1. Francesca Avogadri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jedd D Wolchok
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jedd D Wolchok.

Ethics declarations

Competing interests

J.D.W. is a co-inventor on patents for xenogeneic DNA immunization and an alphavirus replicon particle vaccine for TRP2.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avogadri, F., Wolchok, J. Selecting antigens for cancer vaccines. Nat Biotechnol 30, 328–329 (2012). https://doi.org/10.1038/nbt.2174

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2174

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer